Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.50M | 29.50M | 11.39M | 11.39M | 5.29M |
| Total Receivables | 18.57M | 18.57M | 14.38M | 14.38M | 13.00M |
| Inventory | 1.74M | 1.74M | 3.39M | 3.39M | 3.34M |
| Prepaid Expenses | 852.40K | 852.40K | 4.00M | 4.00M | 3.46M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 978.20K | 978.20K | 369.00K | 369.00K | 180.60K |
| Total Current Assets | 51.64M | 51.64M | 33.53M | 33.53M | 25.27M |
|
|
|||||
| Total Current Assets | 51.64M | 51.64M | 33.53M | 33.53M | 25.27M |
| Net Property, Plant & Equipment | 3.57M | 3.57M | 3.52M | 3.52M | 3.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 262.90K | 262.90K | 147.70K | 147.70K | 148.60K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.77M | 11.77M | 11.54M | 11.54M | 11.92M |
| Total Assets | 67.95M | 67.95M | 49.43M | 49.43M | 41.72M |
|
|
|||||
| Total Accounts Payable | 4.91M | 4.91M | 7.76M | 7.76M | 4.59M |
| Total Accrued Expenses | 2.64M | 2.64M | 2.90M | 2.90M | 3.15M |
| Short-term Debt | 5.86M | 5.86M | 4.43M | 4.43M | 5.48M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 6.90M | 6.90M | 5.52M | 5.52M | 540.10K |
| Total Other Current Liabilities | 6.90M | 6.90M | 5.52M | 5.52M | 540.10K |
| Total Current Liabilities | 20.31M | 20.31M | 20.61M | 20.61M | 13.75M |
|
|
|||||
| Total Current Liabilities | 20.31M | 20.31M | 20.61M | 20.61M | 13.75M |
| Long-Term Debt | 2.14M | 2.14M | 2.08M | 2.08M | -- |
| Short-term Debt | 5.86M | 5.86M | 4.43M | 4.43M | 5.48M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.45M | 22.45M | 22.69M | 22.69M | 13.75M |
|
|
|||||
| Common Stock & APIC | 54.35M | 54.35M | 29.35M | 29.35M | 29.35M |
| Retained Earnings | -7.73M | -7.73M | -502.60K | -502.60K | 995.30K |
| Treasury Stock & Other | -1.11M | -1.11M | -2.10M | -2.10M | -2.37M |
| Total Common Equity | 45.50M | 45.50M | 26.74M | 26.74M | 27.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.50M | 45.50M | 26.74M | 26.74M | 27.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.50M | 45.50M | 26.74M | 26.74M | 27.97M |
|
|
|||||